Following an application from Sylvan Bio Europe BV (‘the applicant’), submitted pursuant to Article 18(1) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to monacolin K in SYLVAN BIO red yeast rice and the maintenance of normal blood LDL-cholesterol concentrations (Question No EFSA-Q-2012-00736). The claim proposed by the applicant was worded as follows: ‘A daily intake of at least 2,4 g of SYLVAN BIO red yeast rice, corresponding to 4,08 mg of monacolin K, contributes to the maintenance of normal blood LDL-cholesterol.’.
Recital 6, Regulation (EU) 2024/2063
In forcesince 30 Jul 2024